These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 15624742)
1. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod. Scott DR J Drugs Dermatol; 2004; 3(6):602. PubMed ID: 15624742 [No Abstract] [Full Text] [Related]
2. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202 [No Abstract] [Full Text] [Related]
4. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Marks R; Owens M; Walters SA; Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200 [No Abstract] [Full Text] [Related]
5. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Shulstad RM Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375 [TBL] [Abstract][Full Text] [Related]
6. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136 [TBL] [Abstract][Full Text] [Related]
7. Imiquimod - Its role in the treatment of cutaneous malignancies. Bubna AK Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465 [TBL] [Abstract][Full Text] [Related]
8. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. van Meurs T; van Doorn R; Kirtschig G Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589 [No Abstract] [Full Text] [Related]